Apolipoprotein B-100/Apolipoprotein A-I Ratio is on Useful Indicator for Coronary Artery Disease in Koreans

Hyung-Kwan Kim, MD, Hyo-Soo Kim, MD, Seil Oh, MD, In-Ho Chae, MD, Lang-A Kim, MD, Eue-Keun Choi, MD, Kyung-Woo Park, MD, Hyun-Jai Cho, MD, Cheol-Ho Kim, MD, Dae-Won Sohn, MD, Byung-Hee Oh, MD, Myoung-Mook Lee, MD, Young-Bae Park, MD and Yun-Shik Choi, MD Heart Research Institute, Seoul National University Medical Research Institute, Department of Internal Medicine, Seoul National University College of Medicine, Cardiovascular Laboratory, Seoul National University Hospital, Seoul, Korea

[1]  Y. Schouw,et al.  Apolipoprotein B and coronary artery disease in women: a cross-sectional study in women undergoing their first coronary angiography. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[2]  Young Sik Kim,et al.  A Case-Control Study on the Risk Factors for Coronary Artery Disease among Korean , 1998 .

[3]  G. Dagenais,et al.  Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec cardiovascular study. , 1996, Circulation.

[4]  Jong Chun Park,et al.  A Study of Plasma Apolipoprotein A-1 and Apolipoprotein B Levels in Patients with Coronary Artery Disease , 1995 .

[5]  Stamatis Adamopoulos,et al.  17β-Estradiol Attenuates Acetylcholine-Induced Coronary Arterial Constriction in Women but Not Men With Coronary Heart Disease , 1995 .

[6]  E. Steyerberg,et al.  Age at menopause as a risk factor for cardiovascular mortality , 1995, The Lancet.

[7]  K. Bailey,et al.  The role of lipoprotein A-I and lipoprotein A-I/A-II in predicting coronary artery disease. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[8]  P. Wilson,et al.  Risk factors that attenuate the female coronary disease advantage. , 1995, Archives of internal medicine.

[9]  A. Quyyumi,et al.  Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. , 1994, Circulation.

[10]  J. Coresh,et al.  Comparison of the plasma levels of apolipoproteins B and A-1, and other risk factors in men and women with premature coronary artery disease. , 1992, The American journal of cardiology.

[11]  K. Anderson,et al.  Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease. , 1992, Journal of the American College of Cardiology.

[12]  A. Zinsmeister,et al.  Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease. , 1983, The New England journal of medicine.

[13]  L. Wilhelmsen,et al.  Alpha-lipoprotein cholesterol concentration in relation to subsequent myocardial infarction in hypercholesterolemic men. , 1980, Atherosclerosis.

[14]  P A Poole-Wilson,et al.  17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. , 1995, Circulation.

[15]  Dong I. Lee,et al.  Production of monoclonal antibodies to human apolipoprotein B-100 and development of a monoclonal antibody-based, competitive enzyme-linked immunoassay for apolipoprotein B , 1993 .

[16]  K. Nielsen [Selective coronary angiography]. , 1970, Nordisk medicin.

[17]  M. P. Judkins,et al.  Selective coronary arteriography. I. A percutaneous transfemoral technic. , 1967, Radiology.